Fri, Feb 27, 2026, 02:49 PM - Updated

Life Science Symposium: Heart Disease in America: Public Enemy Number One

Reply to: Use the form at the right to send messages to this user.
Date: Mon, Dec 18, 2006, 08:00 AM
Date:
Saturday, March 10, 2007.
1:00 PM.<BR/>

Location: Cubberley Auditorium<BR/><BR/>

<p>In the United States each year, nearly 1 million people die from heart disease, while 60 million Americans live with some form of cardiac disease. Moreover, heart disease is the leading cause of death in women of all ages. With a pioneering history of &#8220;firsts,&#8221; including the first heart transplant in the US, the first heart/lung transplant in the world, and one of the first left ventricular assist device procedures in the world, cardiovascular surgery and research at Stanford continues to be a major focus of the School of Medicine. Stanford researchers are working to identify underlying genetic, gender, cellular and molecular factors, as well as environmental and lifestyle factors that contribute to heart disease. At this Saturday symposium co-sponsored by the Stanford Cardiovascular Institute, three leading researchers will ask how it has happened that heart disease has become the number-one killer in the US, and what are we doing about it. They will examine the perceptions and realities of heart disease in America, the outlook for our children, as well as the personal and societal costs of heart disease. They will also cover new and emerging treatments that are being developed at Stanford and elsewhere. </p>
<p>ROBERT C. ROBBINS, Professor of Cardiothoracic Surgery Director, Stanford Cardiovascular Institute</p>
<p>Dr. Robbins has been a member of the faculty at the School of Medicine since 1993. He is Chair of the Department of Cardiothoracic Surgery, the Director of the Stanford Cardiovascular Institute and of the Cardiothoracic Transplantation Program. His current research interests include the use of stem cells for the treatment of congestive heart failure, chronic transplantation rejection, and vascular grafts.</p>
<p>MARK A. HLATKY, Professor of Medicine</p>
<p>Dr. Hlatky is the author of more than 100 scientific papers on cardiac clinical trials and guidelines, and serves as Director of the Cardiovascular Clinical Research Center in the Stanford School of Medicine.</p>
<p>THOMAS ROBINSON, Associate Professor of Pediatrics and of Medicine</p>
<p>Dr. Robinson is the Director of the Center for Healthy Weight and the author of over 100 scientific papers. His research focuses on obesity and cardiovascular disease risk factors in children and adolescents, and on experimental interventions that improve nutrition, increase physical activity, and reduce children's television and media use to prevent obesity, reduce cardiovascular risk and improve child and family health. </p>
<BR/>
please do not message this poster about other commercial services
Why Reserve?
  • - Stake Your Claim: Delist the Post
  • - Signal You're a Serious Buyer
  • - Get the Seller's Direct Contact: Know Who You're Dealing With